Jack Tanselle Joins Huron Life Sciences
November 03 2015 - 7:55AM
Business Wire
New Managing Director Focused on Assisting
Pharmaceutical & Medical Device Companies on Improving
Compliance Program Effectiveness
Huron Consulting Group (NASDAQ: HURN), a leading provider of
business consulting services, today announced that Jack Tanselle
has joined the Company as a managing director in its Huron Life
Sciences practice. Tanselle will support pharmaceutical, medical
device, and diagnostic companies and their suppliers on
identification, mitigation, and management of key business,
operations, and compliance risks.
“Life sciences companies face a proliferation of data,
especially as it concerns the industry's numerous types of
interactions with healthcare professionals, which presents both
opportunities and risks," said Paul J. Silver, managing
director and Huron Life Sciences practice leader. “Jack’s
comprehensive experience and understanding of the entire
life sciences industry value chain will bring practical solutions
to clients and enhance our suite of compliance, strategy, and
operations service offerings. He is an industry leader with many
years of experience helping clients solve problems and improve
their businesses. We are thrilled to have Jack join our team.”
Tanselle has more than 15 years of experience working with
life science clients from the pharmaceutical, biotechnology,
and medical device industries. His experience ranges from
product and therapeutic area strategic planning to enterprise risk
management and compliance program development and
effectiveness. Tanselle joins Huron from Navigant
Consulting Inc., where he served as managing director in
Navigant’s Healthcare and Life Sciences Disputes, Regulatory,
Compliance & Investigations practice. Prior to
starting his career in consulting, Tanselle served as a
product manager at Eli Lilly and Company.
About Huron Life Sciences
Huron Life Sciences serves the continuum of life sciences
organizations, from biopharmaceutical to large multinational
pharmaceutical companies to device and diagnostic manufacturers and
the law and investment firms that support these organizations. Our
unmatched expertise and collaborative approach enable us to deliver
unique solutions that bridge the process of scientific discovery
and sustainable business-model creation with strategies that reduce
the risks associated with regulatory and government scrutiny. Huron
Life Sciences has helped hundreds of organizations across the globe
achieve financial, operational, and strategic objectives to drive
innovation and, ultimately, deliver value to patients. Learn more
at www.huronconsultinggroup.com/lifesciences or follow us on
Twitter: @Huron.
About Huron Consulting Group
Huron Consulting Group helps clients in diverse industries
improve performance, transform the enterprise, reduce costs,
leverage technology, process and review large amounts of complex
data, address regulatory changes, recover from distress, and
stimulate growth. Our professionals employ their expertise in
finance, operations, strategy, analytics, and technology to provide
our clients with specialized analyses and customized advice and
solutions that are tailored to address each client's particular
challenges and opportunities to deliver sustainable and measurable
results. The Company provides consulting services to a wide variety
of both financially sound and distressed organizations, including
healthcare organizations, leading academic institutions, Fortune
500 companies, governmental entities, and law firms. Huron has
worked with more than 450 health systems, hospitals, and academic
medical centers, more than 400 corporate general counsel, and more
than 400 universities and research institutions. Learn more at
www.huronconsultinggroup.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151103005388/en/
Huron Consulting GroupJenna Nichols,
312-880-5693jnichols@huronconsultinggroup.com
Huron Consulting (NASDAQ:HURN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Huron Consulting (NASDAQ:HURN)
Historical Stock Chart
From Sep 2023 to Sep 2024